Vanessa Leguy-Seguin Selected Research

Biomarkers (Surrogate Marker)

4/2024

Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3-related CD27 expression in CD4 T cells in Fabry disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vanessa Leguy-Seguin Research Topics

Disease

4	Fabry Disease (Fabry's Disease) 04/2024 - 01/2018
3	Hereditary Hemorrhagic Telangiectasia 12/2023 - 01/2015
3	Gaucher Disease (Gaucher's Disease) 02/2020 - 02/2019
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017 - 10/2014
2	Cardiomyopathies (Cardiomyopathy) 04/2024 - 02/2022
2	Thrombosis (Thrombus) 01/2018 - 07/2016
1	Inflammation (Inflammations) 04/2024
1	Stroke (Strokes) 04/2024
1	Renal Insufficiency (Renal Failure) 04/2024
1	Hemorrhage 12/2023
1	Telangiectasis (Telangiectasia) 12/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Histiocytosis 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 02/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Hematologic Diseases (Blood Diseases) 12/2017
1	Hemochromatosis (Bronze Diabetes) 12/2017
1	Alcoholism (Alcohol Abuse) 12/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2017
1	Iron Overload 12/2017
1	Hepatitis 07/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2016
1	Epistaxis (Nosebleed) 01/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2013
1	Eosinophilic Fasciitis 03/2013
1	Thrombocytopenia (Thrombopenia) 11/2009
1	Hypersensitivity (Allergy) 03/2007

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2018 - 07/2016
3	Inosine Triphosphate (ITP)IBA 01/2017 - 10/2014
2	GlycosphingolipidsIBA 04/2024 - 02/2022
2	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2015
2	alpha-Galactosidase (Beano)IBA 02/2022 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	globotriaosyl lysosphingolipidIBA 04/2024
1	globotriaosylceramide (globotriosylceramide)IBA 04/2024
1	Monoclonal AntibodiesIBA 12/2023
1	AnticoagulantsIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2022
1	EnzymesIBA 02/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 02/2020
1	Immunoglobulins (Immunoglobulin)IBA 02/2020
1	Glucosylceramides (Glucocerebrosides)IBA 09/2019
1	AcidsIBA 02/2019
1	BilirubinIBA 01/2018
1	Ferritins (Ferritin)IBA 12/2017
1	Transferrin (beta 2 Transferrin)IBA 12/2017
1	IronIBA 12/2017
1	Dapsone FDA Link 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2013
1	Rituximab (Mabthera)FDA Link 03/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2013
1	Deferasirox FDA Link 11/2009
1	SaltsIBA 03/2007
1	PlatinumIBA 03/2007

Therapy/Procedure

8	Therapeutics 01/2023 - 03/2007
1	Drug Therapy (Chemotherapy) 03/2007